Page last updated: 2024-11-06

hydroxyproline and Akinetic-Rigid Variant of Huntington Disease

hydroxyproline has been researched along with Akinetic-Rigid Variant of Huntington Disease in 1 studies

Hydroxyproline: A hydroxylated form of the imino acid proline. A deficiency in ASCORBIC ACID can result in impaired hydroxyproline formation.
hydroxyproline : A proline derivative that is proline substituted by at least one hydroxy group.

Research Excerpts

ExcerptRelevanceReference
"Seven patients with Huntington disease were treated with aminooxyacetic acid (AOAA), an inhibitor of gamma-aminobutyric acid aminotransferase (GABA-T), in an effort to alleviate symptoms by increasing brain GABA content."9.05Failure of aminooxyacetic acid therapy in Huntington disease. ( Allan, BM; Baird, PA; Hansen, S; MacLeod, PM; Perry, TL; Wright, JM, 1980)
"Seven patients with Huntington disease were treated with aminooxyacetic acid (AOAA), an inhibitor of gamma-aminobutyric acid aminotransferase (GABA-T), in an effort to alleviate symptoms by increasing brain GABA content."5.05Failure of aminooxyacetic acid therapy in Huntington disease. ( Allan, BM; Baird, PA; Hansen, S; MacLeod, PM; Perry, TL; Wright, JM, 1980)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Perry, TL1
Wright, JM1
Hansen, S1
Allan, BM1
Baird, PA1
MacLeod, PM1

Trials

1 trial available for hydroxyproline and Akinetic-Rigid Variant of Huntington Disease

ArticleYear
Failure of aminooxyacetic acid therapy in Huntington disease.
    Neurology, 1980, Volume: 30, Issue:7 Pt 1

    Topics: Acetates; Adult; Amino Acids; Aminooxyacetic Acid; Double-Blind Method; Female; Humans; Huntington D

1980